These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1899776)

  • 1. Dynamic QRS-complex and ST-segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. The TEAHAT Study Group.
    Dellborg M; Riha M; Swedberg K
    Am J Cardiol; 1991 Feb; 67(5):343-9. PubMed ID: 1899776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic QRS and ST-segment changes in myocardial infarction monitored by continuous on-line vectorcardiography.
    Dellborg M; Riha M; Swedberg K
    J Electrocardiol; 1990; 23 Suppl():11-9. PubMed ID: 2090727
    [No Abstract]   [Full Text] [Related]  

  • 3. Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group.
    Am J Cardiol; 1990 Feb; 65(7):401-7. PubMed ID: 2106252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.
    Willems JL; Willems RJ; Willems GM; Arnold AE; Van de Werf F; Verstraete M
    Circulation; 1990 Oct; 82(4):1147-58. PubMed ID: 2119263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early intravenous rt-PA on infarct size estimated from serum enzyme activity: results from the TEAHAT Study.
    Risenfors M; Hartford M; Dellborg M; Luepker R; Hjalmarsson A; Swedberg K; Holmberg S; Herlitz J
    J Intern Med Suppl; 1991; 734():11-8. PubMed ID: 1900007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous ST segment recording during thrombolysis in acute myocardial infarction: a report on orthogonal ECG monitoring.
    Badir BF; Nasmith JB; Dutoy JL; Dubé B; Cardinal R; LeBlanc AR; Nadeau R
    Can J Cardiol; 1995; 11(7):545-52. PubMed ID: 7656190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of myocardial ischemia and necrosis by continuous vectorcardiography and measurement of creatine kinase release in patients.
    Sederholm M; Grøttum P; Erhardt L; Kjekshus J
    Circulation; 1983 Nov; 68(5):1006-12. PubMed ID: 6616784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of electrocardiographic scoring systems for the assessment of thrombolytic therapy in acute myocardial infarction. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator.
    Willems JL; Willems RJ; Bijnens I; Doerr R; Verstraete M
    Eur Heart J; 1991 Mar; 12(3):378-88. PubMed ID: 1904028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
    Dorian P; Langer A; Morgan C; Casella L; Harris L; Armstrong P
    Am J Cardiol; 1994 Sep; 74(5):419-23. PubMed ID: 7520209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous vectorcardiography in patients with chest pain indicative of acute ischemic heart disease.
    Lundin P; Eriksson SV; Erhardt L; Strandberg LE; Rehnqvist N
    Cardiology; 1992; 81(2-3):145-56. PubMed ID: 1286473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early thrombolytic therapy in suspected acute myocardial infarction--role of the electrocardiogram: results from the TEAHAT Study.
    Risenfors M; Zukauskiene I; Albertsson P; Hartford M; Lomsky M; Herlitz J
    J Intern Med Suppl; 1991; 734():19-25. PubMed ID: 1900008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous vectorcardiographic changes in relation to scintigraphic signs of reperfusion in patients with acute myocardial infarction receiving thrombolytic therapy.
    Juhlin P; Boström PA; Hansen O; Diemer H; Freitag M; Lilja B; Erhardt L
    J Intern Med; 1996 Jan; 239(1):35-41. PubMed ID: 8551198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous ST- and QRS-vector changes and myoglobin release during streptokinase-treated acute myocardial infarction.
    Strandberg LE; Sylvén C; Erhardt L
    Eur Heart J; 1992 Apr; 13(4):511-6. PubMed ID: 1600991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.
    McNeill AJ; Cunningham SR; Flannery DJ; Dalzell GW; Wilson CM; Campbell NP; Khan MM; Patterson GC; Webb SW; Adgey AA
    Br Heart J; 1989 Apr; 61(4):316-21. PubMed ID: 2496740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal QRS distortion on admission is better than ST-segment measurements in predicting final infarct size and assessing the Potential effect of thrombolytic therapy in anterior wall acute myocardial infarction.
    Birnbaum Y; Maynard C; Wolfe S; Mager A; Strasberg B; Rechavia E; Gates K; Wagner GS
    Am J Cardiol; 1999 Sep; 84(5):530-4. PubMed ID: 10482150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction.
    Villari B; Piscione F; Bonaduce D; Golino P; Lanzillo T; Condorelli M; Chiariello M
    Am J Cardiol; 1990 Dec; 66(19):1281-6. PubMed ID: 2123072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of early thrombolysis on chest pain score reflecting myocardial ischemia in relation to various markers of ischemic damage. TEAHAT Study Group.
    Herlitz J; Dellborg M; Hartford M; Karlson BW; Karlsson T
    Int J Cardiol; 1993 Sep; 41(2):123-31. PubMed ID: 8282435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction.
    Clemmensen P; Ohman EM; Sevilla DC; Wagner NB; Quigley PS; Grande P; Wagner GS
    Am J Cardiol; 1992 Dec; 70(18):1391-6. PubMed ID: 1442606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
    Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
    Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECG evidence of limited myocardial infarction following coronary occlusion treated by early intravenous rt-PA infusion.
    Kelly R; McGuire M; Healey J; Gibbs H; O'Rourke M
    Eur Heart J; 1990 Apr; 11(4):328-33. PubMed ID: 2110064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.